Georgette D. Kanmogne

Author

University of Nebraska Medical Center ORCID

Also Known As

G Kanmogné, G. D. Kanmogne, G.D. Kanmogne, Georgette D Kanmogne, Georgette D. Kanmogne, Georgette Djuidje Kanmogne, Georgette Kanmogne, Marcotte, Thomas D., Wood, Charles

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

University of Nebraska Medical Center Université de Yaoundé I Central Hospital of Yaoundé University Teaching Hospital of Yaounde University of California San Diego

About

Georgette D. Kanmogne is an author at University of Nebraska Medical Center specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	1.2K
2	Natural Sciences	2	2	46
3	Public Health	2	2	165
4	Engineering	1	1	25
5	Health Sciences	1	1	155

Georgette D. Kanmogne

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
HIV-1 gp120 Compromises Blood–Brain Barrier Integrity and Enhance Monocyte Migration across Blood–Brain Barrier: Implication for Viral Neuropathogenesis Georgette D. Kanmogne, Kathy Schall, Jessica Leibhart, Journal of Cerebral Blood Flow & Metabolism	2006	223
HIV-1 gp120 Proteins Alter Tight Junction Protein Expression and Brain Endothelial Cell Permeability: Implications for the Pathogenesis of HIV-Associated Dementia Georgette D. Kanmogne, Charles Primeaux, Paula Grammas Journal of Neuropathology & Experimental Neurology Increased PermeabilityImmunologyNeuroinflammationAlzheimer's DiseaseHuman Retrovirus	2005	155
STAT1 signaling modulates HIV-1–induced inflammatory responses and leukocyte transmigration across the blood-brain barrier Anathbandhu Chaudhuri, Bo Yang, Howard E. Gendelman, Blood	2007	143
Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins Georgette D. Kanmogne, Charles Primeaux, Paula Grammas Biochemical and Biophysical Research Communications InflammationEndothelin-1 SecretionHuman RetrovirusImmunologyEndothelial Dysfunction	2005	128
Creation of a long-acting nanoformulated dolutegravir Brady Sillman, Aditya N. Bade, Prasanta K. Dash, Nature Communications	2018	128
NanoART Synthesis, Characterization, Uptake, Release and Toxicology for Human Monocyte–Macrophage Drug Delivery Ari Nowacek, Reagan L. Miller, JoEllyn McMillan, Nanomedicine	2009	126
Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages Ari Nowacek, Shantanu Balkundi, JoEllyn McMillan, Journal of Controlled Release NanomedicineMedicineImmunologyAntiviral ResponseAntiviral Drug Development	2010	111
Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects Julius Y. Fonsah, Alfred K. Njamnshi, Charles Kouanfack, PLoS ONE Harm ReductionContraceptionPreventive MedicineHiv/aids CounsellingClinical Epidemiology	2017	105
HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood–brain barrier: modulatory effects of STAT1 signaling Bo Ram Yang, Sidra P. Akhter, Anathbandhu Chaudhuri, Microvascular Research InflammationBlood–brain BarrierHuman RetrovirusImmunologyImmune Regulation	2008	90
HIV-1 gp120 Proteins and gp160 Peptides Are Toxic to Brain Endothelial Cells and Neurons: Possible Pathway for HIV Entry into the Brain and HIV-Associated Dementia Georgette D. Kanmogne, Ronald C. Kennedy, Paula Grammas Journal of Neuropathology & Experimental Neurology Gp160 PeptidesBrain MacrophagesImmunologyHiv-1 Gp160 PeptidesNeuroinflammation	2002	84

Page 1